Literature DB >> 20032065

Management of atrial fibrillation.

Carmelo Lafuente-Lafuente1, Isabelle Mahé, Fabrice Extramiana.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032065     DOI: 10.1136/bmj.b5216

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Atrial fibrillation in ventricular-paced rhythm: under-recognised, underdiagnosed and potentially dangerous.

Authors:  Mohammad Alkhalil; Siddhesh Prabhavalkar; Nick Cromie
Journal:  Heart Asia       Date:  2014-02-28

Review 2.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953

3.  Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

Authors:  Hermelinda G Abcede; Bruce Ovbiagele
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-10

Review 4.  Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.

Authors:  Luis Alcocer
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

5.  Regional collaboration to improve atrial fibrillation care: Preliminary data from the Netherlands heart network.

Authors:  Henricus-Paul Cremers; Cassandra Hoorn; Luc Theunissen; Pepijn van der Voort; Peter Polak; Sylvie de Jong; Dennis van Veghel; Lukas Dekker
Journal:  J Arrhythm       Date:  2019-06-01

6.  Age-dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillation.

Authors:  Luc J H J Theunissen; Henricus-Paul Cremers; Dennis van Veghel; Pepijn H van der Voort; Peter E Polak; Sylvie F A M S de Jong; Geert Smits; Jos Dijkmans; Hareld M C Kemps; Lukas R C Dekker; Jeroen A A van de Pol
Journal:  J Arrhythm       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.